UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 285,451 Shares of Integer Holdings Co. (NYSE:ITGR)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its stake in Integer Holdings Co. (NYSE:ITGR - Free Report) by 73.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 104,443 shares of the medical equipment provider's stock after selling 285,451 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.31% of Integer worth $13,841,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of ITGR. Janney Montgomery Scott LLC boosted its position in Integer by 2.0% during the 4th quarter. Janney Montgomery Scott LLC now owns 9,865 shares of the medical equipment provider's stock worth $1,307,000 after acquiring an additional 197 shares during the last quarter. Exchange Traded Concepts LLC boosted its position in Integer by 2.6% during the fourth quarter. Exchange Traded Concepts LLC now owns 5,800 shares of the medical equipment provider's stock valued at $769,000 after purchasing an additional 145 shares during the last quarter. Blue Trust Inc. grew its stake in Integer by 4.4% in the fourth quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider's stock valued at $220,000 after purchasing an additional 71 shares in the last quarter. KBC Group NV increased its position in shares of Integer by 83.3% during the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider's stock worth $212,000 after purchasing an additional 726 shares during the last quarter. Finally, R Squared Ltd acquired a new position in shares of Integer during the 4th quarter worth approximately $44,000. Institutional investors own 99.29% of the company's stock.

Insider Buying and Selling

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the transaction, the chief executive officer now directly owns 47,000 shares in the company, valued at approximately $5,788,990. The trade was a 87.82% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.16% of the stock is currently owned by company insiders.

Integer Stock Performance

Shares of ITGR traded up $2.28 during midday trading on Tuesday, reaching $119.97. 414,820 shares of the stock were exchanged, compared to its average volume of 374,665. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The stock's 50 day simple moving average is $118.63 and its 200 day simple moving average is $128.35. Integer Holdings Co. has a twelve month low of $104.93 and a twelve month high of $146.36. The company has a market cap of $4.19 billion, a P/E ratio of 35.71, a PEG ratio of 1.72 and a beta of 1.03.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. During the same quarter in the previous year, the firm posted $1.14 EPS. The business's revenue for the quarter was up 7.3% compared to the same quarter last year. On average, sell-side analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Wall Street Zen raised shares of Integer from a "sell" rating to a "hold" rating in a research report on Monday, May 19th. Raymond James raised their target price on shares of Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, April 25th. KeyCorp lowered their price target on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Benchmark cut their price objective on Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Finally, Oppenheimer lowered Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. Two investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $145.00.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.